Sedative load among community-dwelling people aged 75 years or older: Association with balance and mobility

Journal of Clinical Psychopharmacology

Volumn 32, Issue 2, 2012, Pages 218-224

  Taipale, Heidi T ^a   Bell, J Simon ^a,b   Gnjidic, Danijela ^c,d,e   Sulkava, Raimo ^a,f   Hartikainen, Sirpa ^a,g  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e Department of Microbiology and Infectious Diseases   (Australia)

^f KUOPIO UNIVERSITY HOSPITAL   (Finland)

^g Leppavirta Health Centre   (Finland)

Author keywords

Aged; Drug utilization; Hypnotics and sedatives; Mobility limitation; Postural balance

Indexed keywords

SEDATIVE AGENT;

AGED; ARTICLE; BALANCE IMPAIRMENT; BODY EQUILIBRIUM; COGNITION; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DRUG CLASSIFICATION; DRUG USE; DRUG UTILIZATION; EDUCATIONAL STATUS; FEMALE; HUMAN; IMMOBILIZATION; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PHYSICAL MOBILITY; PRIORITY JOURNAL; SELF REPORT; TASK PERFORMANCE; WALKING; WALKING DIFFICULTY; WALKING SPEED;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LOGISTIC MODELS; MALE; MOBILITY LIMITATION; MODELS, THEORETICAL; POSTURAL BALANCE; RESIDENCE CHARACTERISTICS; TIME FACTORS; WALKING;

EID: 84857808711     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182485802     Document Type: Article

References (58)

1. Buffett-Jerrott SE, Stewart SH. Cognitive and sedative effects of benzodiazepine use. Curr Pharm Des. 2002;8:45-58. (Pubitemid 34449902)
2. Bourin M, Briley M. Sedation, an unpleasant, undesirable and potentially dangerous side-effect of many psychotropic drugs. Hum Psychopharmacol. 2004;19:135-139. (Pubitemid 38332062)
3. Brown RE, Stevans DR, Haas HL. The physiology of brain histamine. Prog Neurobiol. 2001;63:637-672. (Pubitemid 32119421)
4. Young-McCaughan S, Miaskowski C. Definition of and mechanism for opioid-induced sedation. Pain Manag Nurs. 2001;2:84-97 (Pubitemid 33077261)
5. Berlin I, Warot D, Hergueta T, et al. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J Clin Psychopharmacol. 1993;13:100-106. (Pubitemid 23087225)
6. Hanlon JT, Horner RD, Schmader KE, et al. Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther. 1998;64:684-692. (Pubitemid 29011388)
7. Paterniti S, Dufouil C, Alpérovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol. 2002;22:285-293. (Pubitemid 34546844)
8. McClelland GR. Body sway and the effects of psychoactive drugsVa review. Human Psychopharmacol. 1989;4:3-14. (Pubitemid 19090733)
9. Cutson TM, Gray SL, Hughes MA, et al. Effect of a single dose of diazepam on balance measures in older people. J Am Geriatr Soc. 1997;45:435-440. (Pubitemid 27169218)
10. Ried LD, Johnson RE, Gettman DA. Benzodiazepine exposure and functional status in older people. J Am Geriatr Soc. 1998;46:71-76. (Pubitemid 28037676)
11. Gray SL, Penninx BWJH, Blough DK, et al. Benzodiazepine use and physical performance in community-dwelling older women. J Am Geriatr Soc. 2003;51:1563-1570. (Pubitemid 37409590)
12. Landi F, Russo A, Liperoti R, et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther. 2007;81:235-241. (Pubitemid 46174821)
13. Guralnik JM, LaCroix AZ, Abbott RD, et al. Maintaining mobility in late life. I. Demographic characteristics and chronic conditions. Am J Epidemiol. 1993;137:845-857. (Pubitemid 23149663)
14. Montero-Odasso M, Schapira M, Soriano ER, et al. Gait velocity as a single predictor of adverse events in healthy seniors aged 75 years and older. J Gerontol A Biol Sci Med Sci. 2005;60A:1304-1309. (Pubitemid 41612425)
15. Cooper R, Kuh D, Hardy R. Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ. 2010;341:c4467.
16. Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go test. Phys Ther. 2000;80:896-903.
17. Lajoie Y, Girard A, Guay M. Comparison of the reaction time, the Berg Balance Scale and the ABC in non-fallers and fallers. Arch Gerontol Geriatr. 2002;35:215-225. (Pubitemid 35286417)
18. Taipale HT, Hartikainen S, Bell JS. A comparison of four methods to quantify the cumulative effect of taking multiple drugs with sedative properties. Am J Geriatr Pharmacother. 2010;8:460-471.
19. Linjakumpu T, Hartikainen S, Klaukka T, et al. A model to classify the sedative load of drugs. Int J Geriatr Psychiatry. 2003;18:542-544. (Pubitemid 36763660)
20. Linjakumpu TA, Hartikainen SA, Klaukka TJ, et al. Sedative drug use in the home-dwelling elderly. Ann Pharmacother. 2004;38:2017-2022. (Pubitemid 40169368)
21. Taipale HT, Bell JS, Soini H, et al. Sedative load and mortality among residents of long-term care facilities. A prospective cohort study. Drugs Aging. 2009;26:1-11.
22. Lihavainen K, Sipilä S, Rantanen T, et al. Contribution of musculoskeletal pain to postural balance in community-dwelling people aged 75 years and older. J Gerontol A Biol Sci Med Sci. 2010;65:990-996.
23. Pokela N, Bell JS, Lihavainen K, et al. Analgesic use among community-dwelling people aged 75 years and older: a population-based interview study. Am J Geriatr Pharmacother. 2010;8;233-244.
24. WHO Collaborating Centre for Drug Statistics Methodology. The anatomical therapeutic chemical classification system 2010 [online]. Available at: http://www.whocc.no/atcddd/. Accessed November 24, 2010.
25. Crum RM, Anthony JC, Bassett SS, et al. Population-based norms for the Mini-Mental State Examination by age and education level. JAMA. 1993;269:2386-2391. (Pubitemid 23129378)
26. Groll DL, To T, Bombardier C, et al. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol. 2005;58:595-602. (Pubitemid 40692725)
27. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17:37-49. (Pubitemid 13123113)
28. Furu K, Wettermark B, Andersson M, et al. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106:86-94.
29. Grimby G. Physical activity and muscle training in the elderly. Acta Med Scand Suppl. 1986;711:233-237. (Pubitemid 16008744)
30. LaCroix AZ, Guralnik JM, Berkman LF, et al. Maintaining mobility in late life. II. Smoking, alcohol consumption, physical activity, and body mass index. Am J Epidemiol. 1993;137:858-869. (Pubitemid 23149664)
31. Podsiadlo D, Richardson S. The Timed "Up and Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142-148.
32. Berg KO, Maki BE, Williams JI, et al. Clinical and laboratory measures of postural balance in an elderly population. Arch Phys Med Rehabil. 1992;73:1073-1080.
33. Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167:781-787. (Pubitemid 46658335)
34. Cao YJ, Mager DE, Simonsick EM, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther. 2008;83:422-429. (Pubitemid 351272629)
35. Boudreau RM, Hanlon JT, Roumani YF, et al. Central nervous system medication use and incident mobility limitation in community elders: the health, aging, and body composition study. Pharmacoepidemiol Drug Saf. 2009;18:916-922.
36. Gnjidic D, Cumming RG, Le Couteur DG, et al. Drug burden index and physical function in older Australian men. Br J Clin Pharmacol. 2009;68:97-105.
37. Hilmer SN, Mager DE, Simonsick EM, et al. Drug Burden Index score and functional decline in older people. Am J Med. 2009;122:1142-1149.
38. Gnjidic D, Le Couteur DG, Abernethy DR, et al. Drug Burden Index and Beers criteria: impact on functional outcomes in older people living in self-care retirement villages. J Clin Pharmacol. 2012;52:258-265.
39. Cress ME, Schechtman KB, Mulrow CD, et al. Relationship between physical performance and self-perceived physical function. J Am Geriatr Soc. 1995;43:93-101.
40. Simonsick EM, Newman AB, Nevitt MC, et al. Measuring higher level physical function in well-functioning older adults: expanding familiar approaches in the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2001:56A:M644-M649. (Pubitemid 32954233)
41. Davidoff RA. Antispasticity drugs: mechanisms of action. Ann Neurol. 1985;17:107-116. (Pubitemid 15170430)
42. Wezenberg E, Sabbe BG, Hulstijn W, et al. The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions. J Psychopharmacol. 2007;21:579-587. (Pubitemid 47472724)
43. Hindmarck I. Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder. Int J Clin Pract. 2009;63:1085-1094.
44. Turner C, Handford ADF, Nicholson AN. Sedation and memory: studies with a histamine H-1 receptor antagonist. J Psychopharmacol. 2006;20:506-517. (Pubitemid 43875180)
45. Möhler H, Fritschy JM, Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002;300:2-8. (Pubitemid 34028501)
46. Hartikainen S, Lönnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007;62:1172-1181. (Pubitemid 47599431)
47. Hanlon JT, Bourdreau RM, Roumani YF, et al. Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci. 2009;64:492-498.
48. Ray WA, Griffin MR, Schaffner W, et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med. 1987;316:363-369. (Pubitemid 17034260)
49. Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs. 2003;17:825-837. (Pubitemid 37082985)
50. Pouwels S, van Staa TP, Egberts AC, et al. Antipsychotic use and risk of hip/femur fracture: a population-based case-control study. Osteoporosis Int. 2009;20:1499-1506.
51. Gill TM. Assessment of function and disability in longitudinal studies. J Am Geriatr Soc. 2010;58:5308-5312.
52. Morris R, Harwood RH, Baker R, et al. A comparison of different balance tests in the prediction of falls in older women with vertebral fractures: a cohort study. Age Ageing. 2007;36:78-83. (Pubitemid 47072039)
53. Guralnik JM, Fried PF, Salive ME. Disability as a public health outcome in the aging population. Ann Rev Public Health. 1996;17:25-46. (Pubitemid 26146344)
54. Dawkings K, Potter WZ. Gender differences in pharmacokinetics and pharmacodynamics of psychotropics: focus on women. Psychopharmacol Bull. 1991;27:417-426.
55. Cusack BJ. Pharmacokinetics in older persons. Am J Geriatr Pharmacother. 2004;2:274-302. (Pubitemid 40378782)
56. Wilkinson GR. Drug metabolism and variability among patients in drug response. N Engl J Med. 2005;352:2211-2221.
57. McLachlan AJ, Hilmer SN, Le Couteur DG. Variability in response to medicines in older people: phenotypic and genotypic factors. Clin Pharmacol Ther. 2009;85:431-433.
58. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245. (Pubitemid 12149145)